Neonatal alloimmune thrombocytopenia: Difference between revisions
No edit summary |
|||
| (2 intermediate revisions by one other user not shown) | |||
| Line 43: | Line 43: | ||
==Diagnosis== | ==Diagnosis== | ||
[[Neonatal alloimmune thrombocytopenia history and symptoms| History and Symptoms]] | [[Neonatal alloimmune thrombocytopenia physical examination | Physical Examination]] |[[Neonatal alloimmune thrombocytopenia laboratory findings|Laboratory Findings]] | [[Neonatal alloimmune | [[Neonatal alloimmune thrombocytopenia history and symptoms| History and Symptoms]] | [[Neonatal alloimmune thrombocytopenia physical examination | Physical Examination]] |[[Neonatal alloimmune thrombocytopenia laboratory findings|Laboratory Findings]] | [[Neonatal alloimmune thrombocytopenia x ray|X Ray]] | [[Neonatal alloimmune thrombocytopenia CT|CT]] | [[Neonatal alloimmune thrombocytopenia MRI|MRI]] | [[Neonatal alloimmune thrombocytopenia ultrasound|Ultrasound]] | [[Neonatal alloimmune thrombocytopenia other imaging findings|Other Imaging Findings]] | [[Neonatal alloimmune thrombocytopenia other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== | ||
[[Neonatal alloimmune thrombocytopenia medical therapy|Medical Therapy]] | [[Neonatal alloimmune thrombocytopenia surgery|Surgery]][[Neonatal alloimmune thrombocytopenia primary prevention|Primary Prevention]] | [[Neonatal alloimmune thrombocytopenia secondary prevention|Secondary Prevention]] | [[Neonatal alloimmune thrombocytopenia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Neonatal alloimmune thrombocytopenia future or investigational therapies|Future or Investigational Therapies]] | [[Neonatal alloimmune thrombocytopenia medical therapy|Medical Therapy]] | [[Neonatal alloimmune thrombocytopenia surgery|Surgery]] | [[Neonatal alloimmune thrombocytopenia primary prevention|Primary Prevention]] | [[Neonatal alloimmune thrombocytopenia secondary prevention|Secondary Prevention]] | [[Neonatal alloimmune thrombocytopenia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Neonatal alloimmune thrombocytopenia future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
Latest revision as of 19:40, 21 September 2012
| Neonatal Alloimmune Thrombocytopenia | |
| ICD-10 | P61.0 |
|---|---|
| ICD-9 | 776.1 |
| DiseasesDB | 33767 |
|
Neonatal alloimmune thrombocytopenia Microchapters |
|
Differentiating Neonatal alloimmune thrombocytopenia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Neonatal alloimmune thrombocytopenia On the Web |
|
American Roentgen Ray Society Images of Neonatal alloimmune thrombocytopenia |
|
Directions to Hospitals Treating Neonatal alloimmune thrombocytopenia |
|
Risk calculators and risk factors for Neonatal alloimmune thrombocytopenia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: NAITP; NAIT; NAT; feto-maternal alloimmune thrombocytopenia ; FMAITP; FMAIT
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Neonatal alloimmune thrombocytopenia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination |Laboratory Findings | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies